AERI Aerie Pharmaceuticals Inc.

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Latest News

1. 11 April 2019 Aerie and Inovio Among Pharma Stocks Offering High Risk and Even Higher Upside
2. 10 April 2019 Have Insiders Been Selling Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Shares This Year?
3. 02 April 2019 Aerie Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference
4. 01 April 2019 Aerie Pharmaceuticals Announces Appointment of Gianluca Corbinelli as Chief Commercial Officer - Europe
5. 28 March 2019 Aerie (AERI) Improves 22% YTD: Is Momentum Likely to Sustain?
6. 27 March 2019 Aerie (AERI) Down 2.9% Since Last Earnings Report: Can It Rebound?
7. 25 March 2019 Aerie Pharmaceuticals Announces Four Appointments
8. 22 March 2019 Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan
9. 21 March 2019 Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial in Japan Designed to Support Requirements for Future Regulatory Filing
10. 18 March 2019 Aerie Pharmaceuticals Initiates Phase 2 Clinical Trial of AR-1105 (Dexamethasone Intravitreal Implant) in Patients with Macular Edema Associated with Retinal Vein Occlusion
11. 13 March 2019 Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma
12. 13 March 2019 The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie
13. 12 March 2019 Aerie Pharmaceuticals Announces Full-Year 2019 Net Revenue and Net Cash Burn Guidance
14. 12 March 2019 Aerie Pharmaceuticals Announces U.S. FDA Approval of Rocklatan™ (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the Reduction of Intraocular Pressure in Patients with Open-Angle Glaucoma or Ocular Hypertension
15. 07 March 2019 Introducing Aerie Pharmaceuticals, The Stock That Zoomed 271% In The Last Three Years
16. 05 March 2019 See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc.
17. 05 March 2019 Aerie Pharmaceuticals to Present at Two Investor Conferences in March
18. 01 March 2019 New Research Coverage Highlights Micron Technology, Varian Medical, St. Joe, Himax Technologies, Aerie Pharmaceuticals, and Hexcel — Consolidated Revenues, Company Growth, and Expectations for 2019
19. 01 March 2019 Edited Transcript of AERI earnings conference call or presentation 25-Feb-19 10:00pm GMT
20. 26 February 2019 Aerie (AERI) Q4 Earnings Miss, Rhopressa Gains Traction